CenterBook Partners LP Grows Stock Holdings in Uranium Royalty Corp. $UROY

CenterBook Partners LP grew its holdings in shares of Uranium Royalty Corp. (NASDAQ:UROY) by 828.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,447,408 shares of the company’s stock after buying an additional 3,968,521 shares during the quarter. Uranium Royalty accounts for 0.8% of CenterBook Partners LP’s portfolio, making the stock its 24th largest position. CenterBook Partners LP’s holdings in Uranium Royalty were worth $15,744,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of UROY. Goldman Sachs Group Inc. grew its stake in Uranium Royalty by 25.4% during the first quarter. Goldman Sachs Group Inc. now owns 104,243 shares of the company’s stock worth $183,000 after buying an additional 21,118 shares during the period. Thompson Davis & CO. Inc. purchased a new position in shares of Uranium Royalty in the second quarter valued at $33,000. Vident Advisory LLC boosted its stake in shares of Uranium Royalty by 47.1% in the second quarter. Vident Advisory LLC now owns 1,480,151 shares of the company’s stock valued at $3,700,000 after purchasing an additional 474,030 shares during the period. Corient Private Wealth LLC purchased a new position in shares of Uranium Royalty in the second quarter valued at $29,000. Finally, Quantbot Technologies LP purchased a new position in shares of Uranium Royalty in the third quarter valued at $287,000. 24.19% of the stock is currently owned by hedge funds and other institutional investors.

Uranium Royalty Stock Performance

Shares of UROY stock opened at $3.09 on Monday. Uranium Royalty Corp. has a twelve month low of $2.20 and a twelve month high of $5.52. The company has a market capitalization of $452.96 million, a PE ratio of 154.58 and a beta of 1.37. The firm has a fifty day simple moving average of $3.68 and a 200-day simple moving average of $3.87.

Uranium Royalty (NASDAQ:UROY) last posted its quarterly earnings data on Tuesday, March 10th. The company reported $0.01 EPS for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.02. Uranium Royalty had a net margin of 7.70% and a return on equity of 0.01%. The firm had revenue of $12.25 million for the quarter.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on UROY. Weiss Ratings upgraded shares of Uranium Royalty from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, March 12th. Wall Street Zen downgraded shares of Uranium Royalty from a “buy” rating to a “hold” rating in a research note on Saturday, April 18th. Zacks Research upgraded shares of Uranium Royalty from a “hold” rating to a “strong-buy” rating in a research note on Monday, April 20th. Finally, Raymond James Financial upgraded shares of Uranium Royalty from a “market perform” rating to an “outperform” rating in a research note on Tuesday, April 21st. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, Uranium Royalty presently has a consensus rating of “Buy”.

Uranium Royalty Company Profile

Uranium Royalty Corp. is a Vancouver-based mineral rights acquisition, royalty and streaming company focused exclusively on the uranium sector. Established in early 2021 and listed on the NASDAQ under the symbol UROY, the company seeks to provide investors with leveraged exposure to uranium prices without direct mining risk. Rather than owning or operating mines, Uranium Royalty acquires long-term royalties and streams on both production and development-stage uranium projects worldwide.

The company’s diversified portfolio encompasses royalty interests across multiple jurisdictions, including Canada, the United States, South America, Central Asia and Australia.